Laparoscopic sleeve gastrectomy with Rossetti fundoplication: long-term (5-year) follow-up

Uccelli, Matteo; Cesana, Giovanni; Ciccarese, Francesca; Oldani, Alberto; Giorgi, Riccardo; Carli, Stefano Maria De; Villa, Roberta; Zanoni, Adelinda; Ismail, Ayman; Capua, Francesco Di; Bonaldi, Marta; Rubicondo, Carolina; Moioli, Davide; Olmi, Stefano

doi:10.1016/j.soard.2022.05.012

Cited by 18 publications

(8 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding LSG with fundoplication, a larger volume of the gastric fundus remains compared to conventional LSG, potentially leading to insufficient weight loss and weight gain in the long term. Matteo et al 10 reported that R‐sleeve showed comparable %TWL to that of conventional LSG 5 years post‐surgery. Further study is necessary to elucidate a long‐term outcome and the impact of wrap size on weight loss effect.…”

Section: Discussionmentioning

confidence: 99%

Laparoscopic sleeve gastrectomy combined with Toupet fundoplication (T‐sleeve): A short report of a Japanese obesity patient with gastroesophageal reflux disease

Uno,

Masuda,

Watanabe

et al. 2024

Asian J Endoscop Surgery

View full text Add to dashboard Cite

Laparoscopic sleeve gastrectomy (LSG) is the most frequently performed procedure in bariatric–metabolic surgery (BMS) worldwide, accounting for approximately 90% of BMS procedures in Japan. While numerous studies have reported on the safety and efficacy of LSG, gastroesophageal reflux disease (GERD) remains a major postoperative complication. Although Roux‐en‐Y gastric bypass (RYGB) is preferred for severe obesity with GERD, it is less suitable for Japanese patients who have a higher risk of gastric cancer due to the remnant stomach which is difficult to observe with esophago‐gastro‐duodenoscopy. To address de novo and exacerbation GERD after LSG, we conducted LSG with Toupet fundoplication (T‐sleeve) for Japanese patients with severe obesity. In our first T‐sleeve case, the patient demonstrated sufficient weight loss and improved GERD following surgery. Hence, we suggest that T‐sleeve is a feasible option for Japanese patients with obesity and concurrent GERD.

show abstract

Section: Discussionmentioning

confidence: 99%

Laparoscopic sleeve gastrectomy combined with Toupet fundoplication (T‐sleeve): A short report of a Japanese obesity patient with gastroesophageal reflux disease

Uno,

Masuda,

Watanabe

et al. 2024

Asian J Endoscop Surgery

View full text Add to dashboard Cite

show abstract

“…Due to the prevalence of hiatal hernias in the bariatric population, several studies have explored GERD outcomes when SG is combined with either fundoplication or hiatal hernia repair ( Figure 7 and Figure 8 ) [ 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 ]. The authors acknowledge that the published studies on SG combined with either fundoplication or hiatal hernia repair are investigational, with a limited sample size and variable follow-up.…”

Section: Discussionmentioning

confidence: 99%

“…Abbreviations: ASM = acid suppression medications, BE = Barrett's esophagus, EE = erosive esophagitis, GERD = gastroesophageal reflux disease, NR = not reported, OR = odds ratio, PPI = proton-pump inhibitor, RYGB = Roux-en-Y gastric bypass, SG = sleeve gastrectomy. Due to the prevalence of hiatal hernias in the bariatric population, several studies have explored GERD outcomes when SG is combined with either fundoplication or hiatal hernia repair (Figures 7 and 8) [82][83][84][85][86][87][88][89][90][91][92][93][94]. The authors acknowledge that the published studies on SG combined with either fundoplication or hiatal hernia repair are investigational, with a limited sample size and variable follow-up.…”

Section: Tablementioning

confidence: 99%

Current Management and Treatment Paradigms of Gastroesophageal Reflux Disease following Sleeve Gastrectomy

Masood,

Low,

Deal

et al. 2024

JCM

View full text Add to dashboard Cite

Obesity is associated with serious comorbidities and economic implications. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, are effective options for weight loss and the improvement of obesity-related comorbidities. With the growing obesity epidemic, there has been a concomitant rise in bariatric surgeries, particularly in sleeve gastrectomy, which has been the most widely performed bariatric surgery since 2013. Gastroesophageal reflux disease (GERD) is highly prevalent in obese individuals, can significantly impact quality of life and may lead to serious complications. Obesity and GERD both improve with weight loss. However, as the incidence of sleeve gastrectomy rises, recent data have revealed a risk of exacerbation of pre-existing GERD or the development of de novo GERD following sleeve gastrectomy. We performed a detailed review of GERD post-sleeve gastrectomy, including its overall incidence, pathophysiology and current treatment paradigms.

show abstract

“…43 Fundoplication during or even after SG is another treatment strategy under study in select centers with promising short-term results, but has a potential risk for gastric perforation from fundal ischemia. 44 The most recent expert-modified Delphi consensus on revisions after SG recommended an algorithmic approach with medical therapy first prior to considering RYGB. 45 Staple line leak and bleeding can be devastating complications after SG, and several adjuncts have been proposed to reduce this risk.…”

Section: Sleeve Gastrectomymentioning

confidence: 99%

Updates in Bariatric Surgery

Hsu,

Farrell

2023

The American Surgeon™

View full text Add to dashboard Cite

Bariatric surgery is currently the most effective long-term treatment for morbid obesity as well as type-2 diabetes mellitus. The field of metabolic and bariatric surgery has seen tremendous growth over the past decade with dramatically reduced risks. This article aims to provide an update on bariatric surgery, highlighting the latest outcomes, improvements, and challenges in the field. Recently, the American Society of Metabolic and Bariatric Surgery (ASMBS) and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) released a major update to the indications for bariatric surgery at BMI ≥35 kg/m2 regardless of co-morbidities and 30-34.9 kg/m2 with obesity-related comorbidities. Sleeve gastrectomy has emerged as the most popular bariatric procedure in the last 10 years with its remarkable efficacy and safety profile. The implementation of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) and Enhanced Recovery After Surgery (ERAS) protocols have significantly improved the quality of care for all bariatric patients. The recent introduction and FDA approval of Glucagon-Like Peptide-1 (GLP-1) agonists for chronic obesity has garnered significant media coverage and popularity, but no guidelines exist regarding its use in relation to bariatric surgery. This update underscores the need for tailored approaches, ongoing research, and the integration of evidence-based medicine and innovations to enhance patient care.

show abstract

Laparoscopic sleeve gastrectomy with Rossetti fundoplication: long-term (5-year) follow-up

Cited by 18 publications

References 30 publications

Laparoscopic sleeve gastrectomy combined with Toupet fundoplication (T‐sleeve): A short report of a Japanese obesity patient with gastroesophageal reflux disease

Laparoscopic sleeve gastrectomy combined with Toupet fundoplication (T‐sleeve): A short report of a Japanese obesity patient with gastroesophageal reflux disease

Current Management and Treatment Paradigms of Gastroesophageal Reflux Disease following Sleeve Gastrectomy

Updates in Bariatric Surgery

Contact Info

Product

Resources

About